The number of viable bacteria residing in the human large intestine is more than one trillion per gram of intestinal contents, comprising more than 100 species (3, 13) . They form the intestinal flora and maintain either symbiotic or antagonistic relationships with each other. These intestinal bacteria are said to be classified into three categories, namely, beneficial, harmful or neutral, in relation to human health (13) . Bifidobacteria were first discovered in 1899 by Tissier in the feces of a breast-fed infant. Initially, it was thought that these bacteria reside only in the infant intestine. Since 1957, when Haenell (9) demonstrated that bifidobacteria were a predominant bacteria in the intestines of adults, many ecological studies on intestinal flora and bifidobacteria have been reported (3, 11, 12, 14) . The intestinal flora in hospital patients has been studied in comparison with healthy persons. Benno et al. (15) . These studies clarified that bifidobacteria are predominant in the intestines of humans at every age, and suggested that they have many beneficial effects on the health of humans.
BB536 was initially isolated from the feces of a healthy infant and has been used in many dairy products including fresh milk, yogurt, fermented milk and probiotic products. In this report, we examined the effect of BB536 administration on the fecal flora, fecal putrefactive substances, fecal enzyme activities and other characteristics which indicate the condition of the intestinal environment. Also, the effect of BB536 administration on the defecation frequency and visual fecal characteristics of women volunteers was examined. These studies were performed under the guidelines of the Helsinki Declaration.
MATERIALS AND METHODS
Bacterial strain and administration schedule. BB 536 was isolated from the feces of a breast-fed female baby. It was identified as B. longum on the basis of Table 3 . In both groups, the ammonia concentration was lower during the test period. The decrease in group B was significant when compared with the control period (p < 0.05) while the decrease in group A was not significant. The activity of urease, one of the main enzymes responsible for producing ammonia in the intestine, tended to decrease. It was lower during the test period than other periods. The activity of /3-glucuronidase decreased significantly during the test period in B group. The decrease in tryptophanase was significant when compared with other periods in A group (p < 0.05). Although indole and p-cresol concentrations were lower in both the control and test periods, they did not decrease after BB536 administration. Concentrations  Table 4 shows pH values, water contents and organic acid concentrations of the feces. In both groups, fecal dure. When volunteers are controlled to take the same diet during an experiment, a clearer dose response can be expected. In summary, the administration of BB536 to healthy adults resulted in beneficial changes in fecal flora, putrefactive substances, enzyme activities and fecal characteristics. Also, the administration was effective to increase defecation frequency in volunteers suffering constipation.
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